ALL/AML Classification

The landmark 1999 Golub, Slonim et al study represented the first demonstration that genomic approaches (in this case gene expression profiling) could be used to identify new cancer subtypes or assign tumors to known classes. Here, you can download the original proof-of-concept data demonstrating successful classification between acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) without previous knowledge of these classes.

Contact: 
Todd Golub (golub@broadinstitute.org)
Data Info: 
Description: 

All datasets and supplemental information from Golub, Slonim et al. 1999.

Publication Info: 
Title: 
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
Date: 
10/15/1999
Notes: 
Golub, et al. Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression. Science. 1999 Oct 15;286(5439):531-7.